$0.81−0.05 (−5.98%)
At close: Nov 19, 2026, 4:00 PM ET· Nasdaq · USD
Zhongchao (ZCMD) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue is 41% below its peak, net margin −51.1%.
The four lines that matter · FY21–FY25
Revenue ($K)▼28.3%
11,375.0
FY21→FY25CAGR −8.6%/yr
Net income ($K)▼2026.8%
−5,814.9
one-off year: see footnoteCAGR —
Free cash flow ($K)—
692.8
FY21→FY25CAGR −10.1%/yr
Diluted EPS▼86.9%
−1.85
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+0.0%
3.4mn → 3.4mn diluted shares since FY25. Broadly flat, so EPS moves with net income rather than with the share count.
Capex
$152.6K
−95.0% YoY in FY25 · 1.3% of revenue.
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($K)
-51¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 57.9% → 45.0%. Net margin -51.1% is below the sector median.
The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
USD thousands except per-share & ratios
| Line item | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|
| Revenue & profitability | |||||||
Revenue | 11,375.0 | 15,864.8 | 19,433.9 | 14,151.5 | 16,296.8 | ▼28.3% | −8.6% |
Cost of revenue | 6,253.5 | 6,952.6 | 10,921.8 | 7,794.9 | 6,857.9 | ▼10.1% | −2.3% |
Gross profit | 5,121.5 | 8,912.2 | 8,512.2 | 6,356.7 | 9,438.8 | ▼42.5% | −14.2% |
Research & development | 8.1 | 252.5 | 514.4 | 411.5 | 758.9 | ▼96.8% | −67.9% |
Selling, general & admin | 9,814.1 | 4,990.6 | 6,697.3 | 6,799.6 | 5,863.4 | ▲96.6% | +13.7% |
Total operating expenses | 11,312.8 | 9,253.5 | 21,796.0 | 9,311.1 | 9,759.6 | ▲22.3% | +3.8% |
Operating incomefeeds ROC rank | −6,191.2 | −341.3 | −13,283.8 | −2,954.5 | −320.7 | ▼1714.2% | — |
Other income, net | 422.5 | 403.0 | 1,306.8 | 404.5 | 210.0 | — | — |
Pretax income | −5,768.7 | 61.8 | −11,977.0 | −2,550.0 | −110.8 | — | — |
Income tax | 46.2 | 335.2 | −669.8 | 272.3 | −349.4 | ▼86.2% | −44.6% (22→25) |
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings | −5,814.9 | −273.4 | −11,307.2 | −2,822.3 | 238.7 | ▼2026.8% | — |
| Per share | |||||||
Diluted EPSbuyback-sensitive | −1.85 | −0.99 | −34.83 | −1.13 | 0.10b | ▼86.9% | — |
Diluted shares (mn) | 3.42 | 0.65 | 0.33 | 2.60 | 2.49 | ▲425.3% | +8.2% |
| Margins | |||||||
Gross margin21st pct in Healthcare | 45.0% | 56.2% | 43.8% | 44.9% | 57.9% | ▼11.2pp | −12.9pp |
Operating margin | −54.4% | −2.2% | −68.4% | −20.9% | −2.0% | ▼52.3pp | −52.5pp |
Net margin29th pct in Healthcare | −51.1% | −1.7% | −58.2% | −19.9% | 1.5% | ▼49.4pp | −52.6pp |
FY21 effective tax rate was 315% vs a 6% norm for this window, likely a one-time item; see the filing.FY22 effective tax rate was −11% vs a 6% norm for this window, likely a one-time item; see the filing.b Basic EPS. The company's diluted figure is not in our data feed for this period; its reported basic EPS agrees with net income to common shareholders over basic shares within 2%, so it is shown instead.
4 more years of statements and CSV export are on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-04-03 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Zhongchao's revenue last fiscal year?
Zhongchao reported revenue of $11,375.0K in fiscal 2025, down 28.3% from fiscal 2024.
What was Zhongchao's net income?
Zhongchao reported net income of −$5,814.9K in fiscal 2025, a net margin of −51.1%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

